je.st
news
Cardinal Health to manufacture Bayer cancer drug in new Indiana facility
2014-12-23 08:47:36| Chemicals - Topix.net
Bayer HealthCare and Cardinal Health have signed a 15-year agreement for the contract manufacturing of the castration-resistant prostate cancer drug Xofigo . Under the agreement, Cardinal Health will build a state-of-the art, 64,000 square foot facility in Indianapolis, which will be dedicated exclusively to the manufacturing of Xofigo.
Tags: health
drug
cancer
facility
Category:Chemicals